Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/25 16:09 | 3/13/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Altshuler David | MA | O | EVP, Chi | 6 | S | -6,398 | 495.06 | 0 | -13 | 45 | D | |||||||||||||||
3/12/25 16:11 | 3/10/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Wagner Charles F Jr | MA | O | EVP,CFO | 1 | S | -1,649 | 500.00 | 0 | -3 | 52 | D | |||||||||||||||
3/12/25 16:10 | 3/10/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Tatsis Ourania | MA | O | EVP,Chie | 6 | S | -4,267 | 488.31 | 0 | -9 | 68 | D | |||||||||||||||
2/28/25 16:36 | 2/27/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Atkinson Edward Morrow III | MA | O | EVP,Chie | 3 | S | -2,913 | 472.55 | 0 | -6 | 24 | D | |||||||||||||||
2/26/25 16:06 | 2/25/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Ambrose Kristen | MA | O | SVP,Chie | 3 | S | -1,363 | 465.11 | 0 | -3 | 11 | D | |||||||||||||||
2/19/25 16:28 | 2/18/25 | VRTX | Health | Drug | Pharmaceutical Preparations | Biller Jonathan | MA | O | EVP,GC | 2 | S | -2,333 | 458.30 | 0 | -5 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |